Skip to main content
Imprivata Acquires Verosint to Add AI-Powered Risk Signaling to its Leading Enterprise Access Management Platform
Partners
  • Integrations
  • Resellers
United States
  • United States
  • DACH
  • French
  • United Kingdom
Imprivata logo
United States
  • United States
  • DACH
  • French
  • United Kingdom

Main Nav (2025)

    • State of mobile in healthcare
      Shared mobile devices in healthcare research report
      Our comprehensive report examines the real-world impacts of shared-use mobile devices on healthcare organizations and clinical staff.
      Learn more
    • Left column
      • By Objective
        • Move to passwordless authentication
        • Access shared devices and kiosks
        • Deploy shared mobile devices
        • Control third-party access
        • Address cyber insurance requirements
        • Improve EHR workflows
        • Protect patient privacy
        • Achieve CJIS compliance
        • Face authentication and identity verification
    • Right column
      • By Industry
        • Healthcare
        • Manufacturing
        • State and Local Government
        • Financial Services
        • Gaming
        • Transportation and Logistics
    • Roadmaps
      Product roadmaps
      Explore recently released features and future items.
      Learn more
    • Left column
      • Core capabilities
        • Single Sign-On
        • Multifactor Authentication
        • Mobile Access
        • User Behavior and Access Analytics
        • Privileged Access Management
        • Third Party Access Management
        • Remote Support
        • Identity Threat Detection and Response
    • Right column
      • Healthcare capabilities
        • Patient Privacy Monitoring
        • Drug Diversion Monitoring
        • Medical Device Access Management
        • Biometric Patient Authentication
        • Electronic Prescribing for Controlled Substances (EPCS)
    • About us
      We deliver simple and secure access management solutions for healthcare and other mission-critical industries to ensure every second of crucial work is both frictionless and secure.
      See details
      Contact us
    • Left column
      • Who we are
        • Imprivata culture
        • Corporate responsibility
        • Trust and security
        • Leadership
    • Right column
      • What’s new
        • Newsroom
        • Podcast
        • Awards and recognition
        • Careers
    • Knowledge hub
      The Imprivata Knowledge Hub is a repository of important terms, topics, and solutions related to identity and access management. Browse content by product or industry to learn about securing assets, compliance across sectors, technology glossaries, and advancements in protecting identities and systems.
      Check it out
    • Left column
      • Events
        • Live events
        • On-demand webinars
      • Partners
        • Integration partners
        • Resellers
    • Right column
      • Resources
        • Blog
        • Analyst reports
        • Case studies
        • Whitepapers
        • Datasheets
        • Videos
        • Infographics
        • All resources
    • Connect logo
      Imprivata Connect
      The Imprivata Connect Conference series brings together visionary minds from the Imprivata community for a day of networking and collaboration in the spirit of shaping the future of simple and secure access management for every digital identity.
      Learn more
    • Left column
      • Customer experience
        • Customer success
        • Support services
        • Managed services
        • Clinical services
    • Right column
      • Resources
        • Education center
        • Community portal
        • Product documentation
    • Column
      • 2nd Column
        • Integrations
        • Resellers
  • Post-CTAs
    • Request demo
    • Support
  • Request a demo
  • Support
The search found 3835 results.
News

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.

Press Release

Update on SVB Bank and Imprivata

Imprivata customers,

Waltham, Mass. – March 12, 2023 — With the recent collapse of Silicon Valley Bank, the main question we’re getting is this: “Is Imprivata impacted by what happened at SVB Bank, and if so, how?”

News

The rise of prescription drug abuse and drug diversion

Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The problem is growing as abuse of prescription treatments, such as opioids, stimulants, and sedatives also increases, making the diversion of such treatments increasingly profitable or necessary to fuel addiction.

News

How Providers Should Use Technology to Meet the EPCS Mandate

Digital health technology has been hailed as an important tool for healthcare providers in prescribing medications, but those tools can be used for harm as well as good. That's why federal regulators are very strict in regulating digital prescribing, or e-prescribing.

Datasheets

Imprivata digital identity architecture program

Datasheets

Customers share their experience with Imprivata solutions and services

Datasheets

Management services for Imprivata Privileged Access Management

Case studies

Managed services expertise helps Northumbria Healthcare NHS Foundation Trust improve clinical efficiency and optimise solution investments

Press Release

Imprivata Receives Frost & Sullivan 2012 North American Customer Value Enhancement Award For Speeding Adoption Of Electronic Medical Records

 

Company recognized for keen understanding of clinical workflows and optimization of EMRs

Blog Post

Take a look at the improvements we’ve made to Imprivata Identity Governance 7.4

Discover the latest and greatest Imprivata Identity Governance has to offer...

Pagination

  • First page 
  • Previous page 
  • …
  • Page 59
  • Page 60
  • Page 61
  • Page 62
  • Page 63
  • …
  • Next page 
  • Last page 
United States
  • United States
  • DACH
  • French
  • United Kingdom
  • Company
    • Who we are
    • Leadership
    • History
    • Integrations
    • Resellers
    • Trust and security
    • Careers
    • Newsroom
  • Product
    • Enterprise Access Management
    • Mobile Access Management
    • Mobile Device Access
    • Medical Device Access Management
    • Patient Access
    • Access Compliance
    • Privileged Access Management
    • Vendor Privileged Access Management
    • Customer Privileged Access Management
  • How to buy
    • Request demo
    • Contact us
  • Resources
    • Blog
    • Case studies
    • Analyst reports
    • Whitepapers
    • Datasheets
    • Videos
    • On-demand webinars
    • Infographics
    • Events and webinars
    • Knowledge hub
  • Worldwide headquarters

    20 CityPoint, 6th floor

    480 Totten Pond Rd

    Waltham, MA 02451

    Phone: +1 781 674 2700

    Toll-free: +1 877 663 7446

    International

    London: +44 (0)208 744 6500

    Germany: +49 2173993850

    Australia: +61 3 8844 5533

    France: contactfrance@imprivata.com

    • 
    • 
    • 
    • 
  • Imprivata Logo
  • Post Footer Menu
    • Sitemap
    • Legal
    • Trust and Security
    • Privacy Policy
    • Cookie Policy
  • © 2026 Imprivata, Inc. All rights reserved.